The organization is a global, innovation-driven Pharma & Life Sciences firm, working closely with customers and partners across the healthcare ecosystem to support growth, transformation, and long-term value creation.

-Lead the end-to-end M&A lifecycle, including opportunity sourcing, strategic evaluation, valuation, due diligence, deal structuring, negotiations, and closure

-Front-end complex and cross-border transactions, working closely with global management teams, advisors, bankers, and legal partners

-Partner with the CEO, CFO, Board, and Business Heads to shape and execute the company’s inorganic growth strategy

-Build and manage relationships with investment banks, PE/VC funds, founders, and strategic partners across geographies

-Drive post-merger integration to ensure value realization and strategic alignment

Develop industry insights, target pipelines, and investment theses aligned to long-term business objectives

-Evaluate strategic partnerships, joint ventures, and minority investments alongside full acquisitions

-MBA from a reputed institution with 8+ years of relevant experience

-Strong hands-on experience in M&A / Corporate Development, either within industry or Investment Banking

-Proven ability to front-end and execute complex, cross-border M&A transactions

-Deep understanding of valuation, deal structuring, due diligence, and negotiations

-Strong strategic thinking coupled with high execution rigor

-Ability to work closely with CXOs, Boards, founders, and external advisors across geographies

-Excellent stakeholder management and communication skill

-Opportunity to play a pivotal role in shaping the inorganic growth strategy of a global Pharma & Life Sciences platform

-High-visibility mandate with direct engagement with the CEO, CFO, and Board on strategic M&A initiatives

-Exposure to complex, cross-border transactions across mature and emerging markets